Actively Recruiting
A Real-world Study of Camrelizumab Alone or in Combination With Apatinib/Chemotherapy for Advanced Gastric Cancer
Led by Changzhi People's Hospital Affiliated to Changzhi Medical College · Updated on 2024-07-03
504
Participants Needed
1
Research Sites
152 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this observational study is to evaluate the safety and efficacy of camrelizumab and apatinib in patients with advanced gastric cancer under real-life conditions, particularly in various subgroups of gastric cancer patients, with a view to providing information about the treatment modalities and efficacy of the treatment in real-life gastric cancer patients and to explore the possible predictive biomarkers of prognosis.Patients, who had both decided to be treated with camrelizumab or apatinib prior to enrollment, were entered into one of the following three cohorts at the discretion of the investigator, based on their disease stage and prior treatment
CONDITIONS
Official Title
A Real-world Study of Camrelizumab Alone or in Combination With Apatinib/Chemotherapy for Advanced Gastric Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older, male or female
- Diagnosed with advanced gastric cancer confirmed by pathology or histology
- Patients with disease progression or recurrence after at least 6 months of adjuvant therapy may be included
- At least one measurable lesion on imaging meeting RECIST 1.1 criteria (target lesion ≥10 mm or lymph node ≥15 mm)
- Investigator agrees patient is suitable for treatment with camrelizumab or apatinib
- Willing to enroll voluntarily, with good compliance and follow-up cooperation
You will not qualify if you...
- Pregnant or breastfeeding women
- Prior treatment with immunotherapy drugs such as PD-1, PD-L1, or CTLA4 monoclonal antibodies
- Previous use of other anti-angiogenic agents including apatinib
- Considered unsuitable for study inclusion by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Changzhi People's Hospital Affiliated to Changzhi Medical College
Changzhi, Shanxi, China
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here